FDA is touting at least short-term success for a series of coordinated reforms it initiated in early 2011 to improve its pre-market review processes for medical devices.
CDRH announced its “plan of action” for the 510(k) program and its approach to science in January 2011, including 36...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?